U.S. IPO Weekly Recap: Biotech, Early-Stage Mining, And Bill Ackman Close Out The April IPO Market
Renaissance Capital IPO Research
·
2026-05-02
·
via All Articles on Seeking Alpha
Summary
- Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings.
- Two IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late.
- Street research is expected for one company, and lock-up periods will be expiring for six companies.
aprott/iStock via Getty Images
Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings.
Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
